Cholesteryl ester transfer protein gene polymorphism (I405V) and premature coronary artery disease in an Iranian population
Keywords:Coronary artery disease, premature atherosclerosis, coronary angiography, cholesteryl ester transfer protein, I405V polymorphism
The effect of human cholesteryl ester transfer protein (CETP) expression on atherogenesis is still under debate. The rs5882 (I405V) polymorphism affect CETP function. We aimed to examine the relationship between the rs5882 polymorphism and the risk of angiographically determined coronary artery disease (CAD). To define premature CAD (PCAD), an age cutoff of 55 years for women and 45 years for men was used. An age- and sex-matched case-control study was conducted in 560 patients with newly diagnosed angiographically documented PCAD (≥50% luminal stenosis of any coronary vessel) and an equal number of control patients with normal coronary arteries (no luminal stenosis at coronary arteries). The severity of CAD was determined by vessel score and Gensini score. A real-time polymerase chain reaction (PCR) and high resolution melting analysis were used to distinguish between genotypes. The I405V genotype distributions were not statistically different in CAD and non-CAD groups in univariate and multivariable-adjusted logistic regression analyzes. The median and inter-quartile range for Gensini score was not significantly different among the AA (43, 24 to 73), AG (40, 20 to 66), and GG (45, 25 to 72) genotypes (p = 0.097). Furthermore, the distribution of vessel score did not statistically differ between these genotypes (p = 0.691). Our results suggest that there is no significant association between CETP I405V polymorphism and the risk of PCAD presence and severity. Larger prospective studies are needed to investigate such associations in different populations.
Hamsten A, Eriksson P. Identifying the susceptibility genes for coronary artery disease: From hyperbole through doubt to cautious optimism. J Intern Med 2008;263(5):538-52. http://dx.doi.org/10.1111/j.1365-2796.2008.01958.x.
Libby P. Inflammation in atherosclerosis. Nature 2002;420(6917):868-74. http://dx.doi.org/10.1038/nature01323.
Cengel A, Tanindi A. Myocardial infarction in the young. J Postgrad Med 2009;55(4):305-13. http://dx.doi.org/10.4103/0022-3859.58944.
Celik T, Iyisoy A. Premature coronary artery disease in young patients: An uncommon but growing entity. Int J Cardiol 2010;144(1):131-2. http://dx.doi.org/10.1016/j.ijcard.2008.12.150.
Couch SC, Cross AT, Kida K, Ros E, Plaza I, Shea S, et al. Rapid westernization of children's blood cholesterol in 3 countries: Evidence for nutrient-gene interactions? Am J Clin Nutr 2000;72 5 Suppl:1266S-74.
Vaisi-Raygani A, Ghaneialvar H, Rahimi Z, Nomani H, Saidi M, Bahrehmand F, et al. The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin Biochem 2010;43(15):1189-94. http://dx.doi.org/10.1016/j.clinbiochem.2010.07.010.
Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997;17(1):107-13. http://dx.doi.org/10.1161/01.ATV.17.1.107.
Boekholdt SM, Thompson JF. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 2003;44(6):1080-93. http://dx.doi.org/10.1194/jlr.R200018-JLR200.
Inazu A, Koizumi J, Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 2000;11(4):389-96. http://dx.doi.org/10.1097/00041433-200008000-00008.
Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: Role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 2000;20(2):507-15. http://dx.doi.org/10.1161/01.ATV.20.2.507.
Ghatreh Samani K, Noori M, Rohbani Nobar M, Hashemzadeh Chaleshtori M, Farrokhi E, Darabi Amin M. I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease. Iran Biomed J 2009;13(2):103-8.
Ghatrehsamani K, Darabi M, Rahbani M, Hashemzadeh Chaleshtory M, Farrokhi E, Noori M. Combined hepatic lipase -514C/T and cholesteryl ester transfer protein I405V polymorphisms are associated with the risk of coronary artery disease. Genet Test Mol Biomarkers 2009;13(6):809-15. http://dx.doi.org/10.1089/gtmb.2009.0080.
Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008;299(23):2777-88. http://dx.doi.org/10.1001/jama.299.23.2777.
Wang J, Wang LJ, Zhong Y, Gu P, Shao JQ, Jiang SS, et al. CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population. Lipids Health Dis 2013;12:176. http://dx.doi.org/10.1186/1476-511X-12-176.
Wang Q, Zhou SB, Wang LJ, Lei MM, Wang Y, Miao C, et al. Seven functional polymorphisms in the CETP gene and myocardial infarction risk: A meta-analysis and meta-regression. PLoS One 2014;9(2):e88118. http://dx.doi.org/10.1371/journal.pone.0088118.
Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51(3):606. http://dx.doi.org/10.1016/S0002-9149(83)80105-2.
Boroumand M, Ghaedi M, Mohammadtaghvaei N, Pourgholi L, Anvari MS, Davoodi G, et al. Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography. Clin Biochem 2009;42(9):835-9. http://dx.doi.org/10.1016/j.clinbiochem.2009.01.005.
Boroumand M, Pourgholi L, Ziaee S, Anvari MS, Jalali A, Goodarzynejad H. The association between Factor V Leiden with the presence and severity of coronary artery disease. Clin Biochem 2014;47(6):356-60. http://dx.doi.org/10.1016/j.clinbiochem.2013.12.006.
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62(5):707-14. http://dx.doi.org/10.1016/0002-9343(77)90874-9.
Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, et al. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 2004;11(3):110-21. http://dx.doi.org/10.5551/jat.11.110.
Ridker PM, Pare G, Parker AN, Zee RY, Miletich JP, Chasman DI. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's genome health study. Circ Cardiovasc Genet 2009;2(1):26-33. http://dx.doi.org/10.1161/CIRCGENETICS.108.817304.
Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: Individual patient meta-analysis of 13,677 subjects. Circulation 2005;111(3):278-87. http://dx.doi.org/10.1161/01.CIR.0000153341.46271.40.
Herrera VL, Makrides SC, Xie HX, Adari H, Krauss RM, Ryan US, et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med 1999;5(12):1383-9. http://dx.doi.org/10.1038/70956.
Niu W, Qi Y. Circulating cholesteryl ester transfer protein and coronary heart disease: Mendelian randomization meta-analysis. Circ Cardiovasc Genet 2015;8(1):114-21. http://dx.doi.org/10.1161/CIRCGENETICS.114.000748.
Thompson JF, Durham LK, Lira ME, Shear C, Milos PM. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 2005;181(1):45-53. http://dx.doi.org/10.1016/j.atherosclerosis.2005.01.015.
Wu JH, Lee YT, Hsu HC, Hsieh LL. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: A survey in Taiwan. Atherosclerosis 2001;159(2):451-8. http://dx.doi.org/10.1016/S0021-9150(01)00524-X.
Bruce C, Sharp DS, Tall AR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res 1998;39(5):1071-8.
Isaacs A, Sayed-Tabatabaei FA, Hofman A, Oostra BA, Klungel OH, Maitland-Vander Zee AH, et al. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: The Rotterdam Study. Eur J Cardiovasc Prev Rehabil 2007;14(3):419-21. http://dx.doi.org/10.1097/HJR.0b013e32801101aa.
Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesäniemi YA, Tahvanainen E, et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999;29(2):116-28. http://dx.doi.org/10.1046/j.1365-2362.1999.00412.x.
Blankenberg S, Rupprecht HJ, Bickel C, Jiang XC, Poirier O, Lackner KJ, et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol 2003;41(11):1983-9. http://dx.doi.org/10.1016/S0735-1097(03)00408-X.
Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000;101(16):1907-12. http://dx.doi.org/10.1161/01.CIR.101.16.1907.
Todur SP, Ashavaid TF. Association of CETP and LIPC gene polymorphisms with HDL and LDL sub-fraction levels in a Group of Indian Subjects: A cross-sectional study. Indian J Clin Biochem 2013;28(2):116-23. http://dx.doi.org/10.1007/s12291-012-0259-y.
Zende PD, Bankar MP, Momin AR, Kamble PS. Study of Cholesteryl Ester Transfer Protein (CETP) I405v Genotype and its association with lipid fractions in myocardial infarction patients: A case control study. J Clin Diagn Res 2014;8(6):CC01-4. http://dx.doi.org/10.7860/jcdr/2014/7818.4441.
Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Rejeb NB, Nabli N, et al. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population. J Cardiovasc Med (Hagerstown) 2012;13(9):546-53. http://dx.doi.org/10.2459/jcm.0b013e3283569b24.
Peloso GM, Demissie S, Collins D, Mirel DB, Gabriel SB, Cupples LA, et al. Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J Lipid Res 2010;51(12):3524-32. http://dx.doi.org/10.1194/jlr.P008268.
Padmaja N, Kumar RM, Balachander J, Adithan C. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta 2009;402(1-2):139-45. http://dx.doi.org/10.1016/j.cca.2008.12.041.
Rissanen AM. Familial occurrence of coronary heart disease: Effect of age at diagnosis. Am J Cardiol 1979;44(1):60-6. http://dx.doi.org/10.1016/0002-9149(79)90251-0.